ArticleAmerican journal of clinical and experimental immunology2026
Cancer-associated mutational patterns reshape miRNA regulatory regions and potentially disrupt miRNA-gene interactions.
Article in American journal of clinical and experimental immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
MicroRNAs (miRNAs) are key post-transcriptional regulators frequently dysregulated in cancer, yet how somatic mutational patterns influence miRNA regulatory regions remains unclear. In this study, we integrated mutation profiles, transition-transversion (Ti/Tv) ratios, and miRNA-gene interaction analyses across multiple TCGA cancer subtypes to investigate how mutation patterns may affect miRNA binding regions. miRNA interactions were strongly enriched in 3' untranslated regions (3'UTRs), with fewer interactions observed in coding sequences (CDS). Across cancers, miRNA regions exhibited moderate GC content (~51%), which typically predicts elevated Ti/Tv ratios; however, most cancer cohorts showed markedly reduced Ti/Tv ratios, indicating a shift toward transversion-heavy mutational processes. Because transversions generally produce greater nucleotide class changes than transitions, this shift may increase the likelihood of disrupting sequence-specific miRNA binding. Supporting this, we identified missense mutations overlapping predicted miRNA binding sites within coding regions, highlighting a potential intersection between somatic mutations and post-transcriptional regulation. Together, these findings suggest that cancer-associated mutational patterns may reshape miRNA regulatory regions and alter miRNA-gene interactions, providing insight into how somatic mutations impact gene regulation beyond protein-coding changes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.